Lomond Therapeutics
Pre-clinicalTargeting escape mutations in hematological cancers with first and best in class medicines.
Founded
2021
Focus
Small Molecules
About
Targeting escape mutations in hematological cancers with first and best in class medicines.
Funding History
2Total raised: $59M
Series A$55MAtlas VentureNov 15, 2022
Seed$4MAtlas VentureMar 15, 2021
Company Info
TypePrivate
Founded2021
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile